149 related articles for article (PubMed ID: 32116256)
1. Neuropathological Correlates of Cumulative Benzodiazepine and Anticholinergic Drug Use.
Richardson K; Wharton SB; Grossi CM; Matthews FE; Fox C; Maidment I; Loke YK; Steel N; Arthur A; Myint PK; Boustani M; Campbell N; Robinson L; Brayne C; Savva GM
J Alzheimers Dis; 2020; 74(3):999-1009. PubMed ID: 32116256
[TBL] [Abstract][Full Text] [Related]
2. Anticholinergic and benzodiazepine medication use and risk of incident dementia: a UK cohort study.
Grossi CM; Richardson K; Fox C; Maidment I; Steel N; Loke YK; Arthur A; Myint PK; Campbell N; Boustani M; Robinson L; Brayne C; Matthews FE; Savva GM
BMC Geriatr; 2019 Oct; 19(1):276. PubMed ID: 31638906
[TBL] [Abstract][Full Text] [Related]
3. Exposure to Strong Anticholinergic Medications and Dementia-Related Neuropathology in a Community-Based Autopsy Cohort.
Gray SL; Anderson ML; Hanlon JT; Dublin S; Walker RL; Hubbard RA; Yu O; Montine TJ; Crane PK; Sonnen JA; Keene CD; Larson EB
J Alzheimers Dis; 2018; 65(2):607-616. PubMed ID: 30056417
[TBL] [Abstract][Full Text] [Related]
4. Association of Benzodiazepine and Anticholinergic Drug Usage With Incident Dementia: A Prospective Cohort Study of Community-Dwelling Older Adults.
Hafdi M; Hoevenaar-Blom MP; Beishuizen CRL; Moll van Charante EP; Richard E; van Gool WA
J Am Med Dir Assoc; 2020 Feb; 21(2):188-193.e3. PubMed ID: 31300339
[TBL] [Abstract][Full Text] [Related]
5. Clinical correlates of cortical and nucleus basalis pathology in Alzheimer dementia.
Samuel W; Terry RD; DeTeresa R; Butters N; Masliah E
Arch Neurol; 1994 Aug; 51(8):772-8. PubMed ID: 8042925
[TBL] [Abstract][Full Text] [Related]
6. Cognitive decline associated with anticholinergics, benzodiazepines and Z-drugs: Findings from The Irish Longitudinal Study on Ageing (TILDA).
Moriarty F; Savva GM; Grossi CM; Bennett K; Fox C; Maidment I; Loke YK; Steel N; Kenny RA; Richardson K
Br J Clin Pharmacol; 2021 Jul; 87(7):2818-2829. PubMed ID: 33270264
[TBL] [Abstract][Full Text] [Related]
7. Neuropathological changes in the nucleus basalis correlate with clinical measures of dementia.
Iraizoz I; Guijarro JL; Gonzalo LM; de Lacalle S
Acta Neuropathol; 1999 Aug; 98(2):186-96. PubMed ID: 10442559
[TBL] [Abstract][Full Text] [Related]
8. Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: a retrospective analysis.
Irwin DJ; Grossman M; Weintraub D; Hurtig HI; Duda JE; Xie SX; Lee EB; Van Deerlin VM; Lopez OL; Kofler JK; Nelson PT; Jicha GA; Woltjer R; Quinn JF; Kaye J; Leverenz JB; Tsuang D; Longfellow K; Yearout D; Kukull W; Keene CD; Montine TJ; Zabetian CP; Trojanowski JQ
Lancet Neurol; 2017 Jan; 16(1):55-65. PubMed ID: 27979356
[TBL] [Abstract][Full Text] [Related]
9. Use of Benzodiazepines and Risk of Incident Dementia: A Retrospective Cohort Study.
Gerlach LB; Myra Kim H; Ignacio RV; Strominger J; Maust DT
J Gerontol A Biol Sci Med Sci; 2022 May; 77(5):1035-1041. PubMed ID: 34410381
[TBL] [Abstract][Full Text] [Related]
10. Cell loss in the nucleus basalis is related to regional cortical atrophy in Alzheimer's disease.
Cullen KM; Halliday GM; Double KL; Brooks WS; Creasey H; Broe GA
Neuroscience; 1997 Jun; 78(3):641-52. PubMed ID: 9153647
[TBL] [Abstract][Full Text] [Related]
11. One-Year Evaluation of a Targeted Medication Therapy Management Intervention for Older Adults.
Martinez AI; Abner EL; Jicha GA; Rigsby DN; Eckmann LC; Huffmyer MJ; Moga DC
J Manag Care Spec Pharm; 2020 Apr; 26(4):520-528. PubMed ID: 32223601
[TBL] [Abstract][Full Text] [Related]
12. Age, neuropathology, and dementia.
Savva GM; Wharton SB; Ince PG; Forster G; Matthews FE; Brayne C;
N Engl J Med; 2009 May; 360(22):2302-9. PubMed ID: 19474427
[TBL] [Abstract][Full Text] [Related]
13. Is Benzodiazepine Use Associated With the Risk of Dementia and Cognitive Impairment-Not Dementia in Older Persons? The Canadian Study of Health and Aging.
Nafti M; Sirois C; Kröger E; Carmichael PH; Laurin D
Ann Pharmacother; 2020 Mar; 54(3):219-225. PubMed ID: 31595772
[No Abstract] [Full Text] [Related]
14. Drugs with anticholinergic properties, cognitive decline, and dementia in an elderly general population: the 3-city study.
Carrière I; Fourrier-Reglat A; Dartigues JF; Rouaud O; Pasquier F; Ritchie K; Ancelin ML
Arch Intern Med; 2009 Jul; 169(14):1317-24. PubMed ID: 19636034
[TBL] [Abstract][Full Text] [Related]
15. Long-term anticholinergic, benzodiazepine and Z-drug use in community-dwelling older adults: What is the impact on cognitive and neuropsychological performance?
Dyer AH; Laird E; Hoey L; Hughes CF; McNulty H; Ward M; Strain JJ; Molloy AM; Cunningham C; McCarroll K
Int J Geriatr Psychiatry; 2021 Nov; 36(11):1767-1777. PubMed ID: 34227695
[TBL] [Abstract][Full Text] [Related]
16. Association between Anticholinergic Medication Use and Risk of Dementia among Patients with Parkinson's Disease.
Sheu JJ; Tsai MT; Erickson SR; Wu CH
Pharmacotherapy; 2019 Aug; 39(8):798-808. PubMed ID: 31251824
[TBL] [Abstract][Full Text] [Related]
17. Anticholinergic drugs and forebrain magnetic resonance imaging changes in cognitively normal people and those with mild cognitive impairment.
Meng D; Mohammadi-Nejad AR; Sotiropoulos SN; Auer DP;
Eur J Neurol; 2022 May; 29(5):1344-1353. PubMed ID: 35129272
[TBL] [Abstract][Full Text] [Related]
18. Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease.
Hanna Al-Shaikh FS; Duara R; Crook JE; Lesser ER; Schaeverbeke J; Hinkle KM; Ross OA; Ertekin-Taner N; Pedraza O; Dickson DW; Graff-Radford NR; Murray ME
JAMA Neurol; 2020 Feb; 77(2):225-233. PubMed ID: 31657834
[TBL] [Abstract][Full Text] [Related]
19. Benzodiazepine use and risk of incident dementia or cognitive decline: prospective population based study.
Gray SL; Dublin S; Yu O; Walker R; Anderson M; Hubbard RA; Crane PK; Larson EB
BMJ; 2016 Feb; 352():i90. PubMed ID: 26837813
[TBL] [Abstract][Full Text] [Related]
20. Does Anticholinergic Activity Affect Neuropathology? Implication of Neuroinflammation in Alzheimer's Disease.
Yoshiyama Y; Kojima A; Itoh K; Isose S; Koide M; Hori K; Arai K
Neurodegener Dis; 2015; 15(3):140-8. PubMed ID: 26138491
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
